Drawing for IMEDEEN

USPTO serial 79022571

IMEDEEN

Reviewed by CopyMark Law Group

Reg. 3211669Status 404
Filing date
Status date
Registration date
Feb 20, 2007
Examiner
AWRICH, ELLEN
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IMEDEEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michele A. Farber

Michele A. Farber Pfizer Inc.235 East 42nd StreetNew York, NY 10017UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003[ Non-medicated cosmetic preparations for care, cleaning and improvement of skin, hair, nails, eyes, lips and teeth; non-medicated cosmetic preparations for cellulite treatment; non-medicated sun care preparations, namely, oils, creams, lotions, gels, sticks and powder all for sun tan, sun block and sun protection ]SECTION 71 - CANCELLED
005[ Medicated skin care preparations; medicinal creams for skin care; ] pharmaceutical preparations for improving skin softness and thickness and to counteract drying and formation of wrinkles; [ nutritional supplements in lotion form for skin care; ] dietary and nutritional food supplements; [ dietary supplemental drinks; meal replacement drinks; nutritional drink mix for use as a meal replacement; diet pills and capsules ]SECTION 70 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 20, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Aug 20, 2026DETHDEATH OF INTERNATIONAL REGISTRATION
Oct 14, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED
May 6, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 18, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 6, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 11, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED
Aug 17, 2017ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 15, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED
Feb 23, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED
Sep 15, 2016RNWLINTERNATIONAL REGISTRATION RENEWED
Aug 26, 2016DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Aug 26, 2016DETHDEATH OF INTERNATIONAL REGISTRATION
Aug 3, 2016NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Aug 3, 201671AGREGISTERED-SEC.71 ACCEPTED
Jul 27, 2016EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Apr 1, 2016PR71POST REGISTRATION ACTION MAILED - SEC.71
Feb 22, 201671AFREGISTERED-SEC.71 FILED
Feb 22, 2016ES71TEAS SECTION 71 RECEIVED
Feb 20, 2016REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Feb 19, 2015INNPPARTIAL INVALIDATION PROCESSED BY THE IB
Jun 9, 2014INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 9, 2014INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 9, 2014INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Oct 26, 2013ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 1, 2013INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 29, 2013ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 19, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED
Feb 1, 2013NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Feb 1, 201371.PREGISTERED - PARTIAL SEC 71 ACCEPTED
Feb 1, 2013APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 18, 201371AFREGISTERED-SEC.71 FILED
Jan 18, 2013ES71TEAS SECTION 71 RECEIVED
Oct 23, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 23, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 13, 2007FINVFINAL DECISION TRANSACTION PROCESSED BY IB
Sep 12, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB
Sep 6, 2007FIMPFINAL DISPOSITION PROCESSED
Sep 5, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 20, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 5, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 15, 2006NPUBNOTICE OF PUBLICATION
Oct 11, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 6, 2006ALIEASSIGNED TO LIE
Oct 3, 2006CNEAEXAMINERS AMENDMENT MAILED
Oct 3, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 3, 2006XAECEXAMINER'S AMENDMENT ENTERED
Oct 3, 2006CNEAEXAMINERS AMENDMENT -WRITTEN
Sep 29, 2006ACECAMENDMENT FROM APPLICANT ENTERED
Sep 1, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 1, 2006MAILPAPER RECEIVED
Aug 10, 2006RFNTREFUSAL PROCESSED BY IB
Jul 27, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 27, 2006RFRRREFUSAL PROCESSED BY MPU
Jul 27, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 26, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 26, 2006DOCKASSIGNED TO EXAMINER
May 12, 2006NWAPNEW APPLICATION ENTERED
May 11, 2006REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance